ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,648.22
0.30%
US Tech 100
19,826.80
-0.10%
다우존스 지수
40,752.29
1.34%
Bitcoin
64,494.08
-0.54%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VNDA
일자시간출처헤드라인심볼기업
2014/02/1421:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2014/02/1321:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2014/02/1321:00PR Newswire (US)Vanda Pharmaceuticals Reports Fourth Quarter 2013 and Full Year 2013 ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2014/02/0707:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2014/02/0107:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2014/02/0103:45PR Newswire (US)FDA Approves HETLIOZ™ (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake DisorderNASDAQ:VNDAVanda Pharmaceuticals Inc
2014/01/3120:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2014/01/2407:00PR Newswire (US)Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014NASDAQ:VNDAVanda Pharmaceuticals Inc
2014/01/0101:50ZacksPipeline Setback at Can-Fite BioPharma, Shares Down - Analyst BlogNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/3104:51ZacksActavis' Women Health Biz Update - Analyst BlogNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/2405:00ZacksAffymetrix Reaches New 52-Week High - Analyst BlogNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/1723:04ZacksAgenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the TapeNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/1702:00ZacksLabel of Gilead's Complera Expanded - Analyst BlogNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/1302:00ZacksFDA Panel Votes for AZN/BMY's Drug - Analyst BlogNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/0407:00PR Newswire (US)Vanda Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/0318:28ZacksPharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst InterviewsNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/0318:28ZacksPharma & Biotech Stock Outlook - Dec 2013 - Industry OutlookNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/0318:28ZacksPharma & Biotech Stock Outlook - Dec 2013 - Industry OutlookNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/0318:28ZacksPharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst InterviewsNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/12/0318:28ZacksPharma & Biotech Stock Outlook - Dec 2013 - Industry OutlookNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1523:14Dow Jones NewsU.S. Hot Stocks Futures: Hot Stocks to WatchNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1522:39Dow Jones NewsKingdon Capital Management 3Q 13F: Holdings As Of -2-NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1522:39Dow Jones NewsKingdon Capital Management 3Q 13F: Largest PurchasesNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1522:39Dow Jones NewsKingdon Capital Management 3Q 13F: Holdings As Of Sep 30NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1521:07Dow Jones NewsTwo Sigma Investments 3Q 13F: Largest EliminationsNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1521:07Dow Jones NewsTwo Sigma Investments 3Q 13F: Largest Eliminations -2-NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1521:07Dow Jones NewsTwo Sigma Investments 3Q 13F: Largest Eliminations -2-NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1521:07Dow Jones NewsTwo Sigma Investments 3Q 13F: Largest Eliminations -2-NASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1521:07Dow Jones NewsTwo Sigma Investments 3Q 13F: Largest PurchasesNASDAQ:VNDAVanda Pharmaceuticals Inc
2013/11/1521:07Dow Jones NewsTwo Sigma Investments 3Q 13F: Largest SalesNASDAQ:VNDAVanda Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:VNDA

최근 히스토리

BIT
WSAC25
Saccheria Flli Francesch...
LSE
BRAM
Brammer
BIT
P1WN33
NLBNPIT1WN33 20991231 6....
BIT
P1BG03
BNP Paribas Issuance
BIT
S28292
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유